Keith S. Lanier

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321

Bart Barlogie, Robert A. Kyle, Kenneth C. Anderson et al. · Journal of Clinical Oncology · 2006 · 495 citations · Full text

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer · 2010 · 248 citations · Full text

Ncctg Trial N06ca, Health Sciences, Peripheral Nerve Injury +10

Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07

Stephanie R. Land, Jacek A Kopec, Reena S. Cecchini et al. · Journal of Clinical Oncology · 2007 · 237 citations · Full text